Hindustan Bio Sciences informs about outcome of board meeting

31 Oct 2025 Evaluate
Hindustan Bio Sciences has informed that pursuant to Regulation 30 and other applicable Regulations of SEBI (LODR), 2015, the Board of Directors of the Company in its meeting held today i.e., on October 81, 2025 approved the Un-Audited Standalone Financial Results of the company for the 5 Quarter ended on 30th September 2025 along with the Limited Review Report. The meeting commenced at 02:00 PM and concluded at 4.30 PM.

The above information is a part of company’s filings submitted to BSE.

Hind Bio Science Share Price

5.13 -0.26 (-4.82%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×